<i>TP53</i> Co-Mutation Status Association with Clinical Outcomes in Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer

<i>TP53</i> Co-Mutation Status Association with Clinical Outcomes in Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer

<i>TP53</i> co-mutations have shown association with poor prognosis in various solid tumors. For <i>EGFR</i>-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist regarding its impact on survival. Clinical outcomes and genomic data were obtained retr...

Full description

Bibliographic Details
Main Authors: Xiuning Le, Cliff Molife, Mark S. Leusch, Maria Teresa Rizzo, Patrick M. Peterson, Nicola Caria, Yongmei Chen, Elena Gonzalez Gugel, Carla Visseren-Grul
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
advanced non-small cell lung cancer
<i>EGFR</i>
<i>EGFR</i>-TKI
<i>TP53</i>
overall survival
progression-free survival
Online Access:https://www.mdpi.com/2072-6694/14/24/6127

Internet

https://www.mdpi.com/2072-6694/14/24/6127

Similar Items